Latest Articles

Perceptions and Barriers on the use of PCSK9 inhibitors

Treatment simplification in T2D: A less-is-more approach to help reduce the burden of disease

Prognostic impact of achieving LDL cholesterol guidelines

Cardiovascular Disease in Saudi Arabia: Facts and the Way Forward

PCSK9 inhibitors and ACS

PCSK9 Inhibitors in Cardiovascular Disease

PCSK9i and Prevention of CVD

The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.

PCSK9 Inhibitors in Real World Practice

PCSK9i after hospital discharge for acute MI

Factors associated with time to PCSK9i initiation following hospital discharge for acute myocardial infarction.